publication venue for
- Lithium toxicity following co-prescription of lithium and angiotensin-converting enzyme (ACE) inhibitors/angiotensin II receptor blockers (ARBs) 2023
- Hydroxysine initiation following drug safety advisories on cardiac arrhythmias in the UK and Canada: A longitudinal cohort study 2022
- Treatment effects of angiotensin-converting enzyme inhibitors and angiotensin receptor blockers in people underrepresented from the ontarget trial: Analysis of routinely collected data using trial replication methods 2022
- A decision aid to drive adherence to controller treatments in mild asthma: A rapid-cycle design study 2021
- Influence of drug safety advisories on drug utilization: An international interrupted time series and meta-analysis study 2021
- Head to head comparisons of therapies using real world data: What is needed to emulate target trials? 2020
- Real-world cost-effectiveness of direct oral anticoagulants in the Quebec setting 2020
- Data variability across Canadian administrative health databases: Differences in content, coding, and completeness 2020
- A simulation-based comparison of confounding adjustment methods in observational studies of administrative data 2019
- Misoprostol as an adjunct to oxytocin can reduce postpartum hemorrhage among pregnant women delivering in Bamenda Cameroon, 2015-2016: a propensity score-matched retrospective chart review 2019
- The devil you should know: Adjustment for confounding bias is rare in observational economic evaluations in cardiology 2019
- Identification of incident pancreatic cancer in administrative health data: A validation study by the Canadian Network for Observational Drug Effect Studies (CNODES) 2018
- Real-world use of dulaglutide in Europe: A multi-country drug utilization study 2018
- Use of Attention Deficit Hyperactivity Disorder Medication Amongst Adults in Quebec, Canada 2017
- Real-World Effectiveness of Omalizumab for the Treatment of Severe Asthma 2016
- Trends in Oral Glucocorticoid Utilization Among Older Adults with Respiratory Disease 2016
- Association between Genetic Polymorphisms of Drug-metabolizing Enzymes and Transporters and Anti-tuberculosis Drug-induced Liver Injury in a Chinese Population 2015
- Beta Blockers and the Risk of Suicide in the Elderly 2015
- Efficacy of Osteoporosis Pharmacotherapies in Preventing Fractures among Chronic Oral Glucocorticoids Users: A Network Meta-analysis 2015
- Lipophilic Statins and the Risk of Suicide: A Population-based Study 2015
- Predictors of Ontario's Medication Review Program (MedsCheck Annual Service) Utilization Among Ontario Seniors 2015
- Psychiatric Healthcare Utilization and Related Costs in Newly Diagnosed Individuals with Autism Spectrum Disorder (ASD) in Quebec (Canada) 2015
- women’s Values and Preferences: Decision Making about Thromboprophylaxis in Pregnancy: 445. 2015
- Adverse Reactions Associated To Biologics for Psoriasis in Brazil 2014
- Follow-Up of Psychoactive Drug Use in Newly Diagnosed Patients with Autism Spectrum Disorder (ASD) in Quebec (Canada) 2014
- Incretin Therapy and Risk of Pancreatitis in Type 2 Diabetes Mellitus: Systematic Review of Randomized and Non-Randomized Studies 2014
- Psychiatric Health Care Utilisation and Related Costs in Newly Diagnosed Patients with Autism Spectrum Disorder (ASD) in Quebec (Canada) 2014
- Gastrointestinal Adverse Events of Glucagon-Like Peptide-1 Receptor Agonists for Type 2 Diabetes Mellitus: A Pairwise and Network Meta-Analysis 2013
- Potential for Selection Bias in the Context of a Restriction Drug Access Program: The Case of Atomoxetine in Quebec, Canada 2013
- Beware of Policy-Induced Selection Bias in Drug Effect Studies: Example in the Comparative Effectiveness of Oral Bisphosphonates 2012
- Direct Cost of Schizophrenia in Quebec, Canada: An Incidence-Based Microsimulation Monte-Carlo Markov Model 2011
- Factors Associated with the Schizophrenia Specific States: A Population-Based Study 2010
- Validation of a Monte-Carlo Markov Model for Schizophrenia 2010
- A method for estimating the completeness of a literature search 2008
- An exploration of methodologies to individualize and integrate warfarin's benefit and harm 2008
- Concomitant use of cardiovascular related medications in diabetic patients receiving rosiglitazone 2008
- Consent for use of health information (HI) for research: Comparison of patient and general public attitudes 2008
- Evaluation of pharmacoepidemiology trials: Rigour methodologica versus rigor mortis 2008
- Causality assessment of adverse events in oncology clinical trials: A qualitative study 2007
- Community-based global cardiovascular risk reduction with pharmacotherapy for modifiable risk factors in high-risk patients 2007
- Development and validation of an adverse event causality assessment tool for use in oncology clinical trials 2007
- Orthogonal experimental designs disentangle confounding in database studies 2007
- Quantitative risk-benefit analysis of alosetron in irritiable bowel syndrome: A patient-level meta-cohort analysis 2007
- Enhancing signal detection for pharmacovigilance using pharmacogenomics 2006
- Is statin therapy associated with a decreased risk for bleeding in patients with chronic atrial fibrillation who are receiving warfarin? A population-based nested case-control study 2006
- Making a curriculum vita numerical and graphical for tenure, promotion and career awards 2006
- Pre‐ and post‐stroke oral antithrombotics and mortality in patients with ischaemic stroke. 31:1182-1189. 2022
- A comparison of confounder selection and adjustment methods for estimating causal effects using large healthcare databases. 31:424-433. 2022
- Initial opioid prescription patterns and the risk of ongoing use and adverse outcomes. 30:379-389. 2021
- Impact of delisting high‐strength opioid formulations from a public drug benefit formulary on opioid utilization in Ontario, Canada. 28:726-733. 2019
- Trends and uptake of new formulations of controlled‐release oxycodone in Canada. 27:520-525. 2018
- Risk of rhabdomyolysis from 5‐α reductase inhibitors. 27:351-355. 2018
-
Comparison of the ability of double‐robust estimators to correct bias in propensity score matching analysis.
A M onteC arlo simulation study. 26:1513-1519. 2017 - Pattern of in‐hospital changes in drug use in the older people from 2010 to 2016. 26:1534-1539. 2017
-
Pregabalin and heart failure:
A population‐based study. 26:1087-1092. 2017 - Changes in clinical outcomes for community-dwelling older people exposed to incident chronic polypharmacy: a comparison between 2001 and 2009. 25:204-211. 2016
- Adherence to osteoporosis pharmacotherapy is underestimated using days supply values in electronic pharmacy claims data. 24:67-74. 2015
- Drug–drug interactions in a cohort of hospitalized elderly patients. 22:1054-1060. 2013
- A systematic review of validated methods for identifying orthopedic implant removal and revision using administrative data. 21:265-273. 2012
- Palatability, adherence and prescribing patterns of antiretroviral drugs for children with human immunodeficiency virus infection in Canada. 20:1246-1252. 2011
- Hospitalization and surgical rates in patients with Crohn's disease treated with infliximab: a matched analysis. 20:838-848. 2011
- Concordance between discharge prescriptions and insurance claims in post‐myocardial infarction patients. 16:207-215. 2007
- Anti-infectives-induced adverse drug reactions in hospitalized patients. 14:501-506. 2005
- Understanding drug–herb interactions. 12:427-430. 2003
- The use of surrogate endpoints in clinical trials: focus on clinical trials in cardiovascular diseases. 10:497-508. 2001
- Proportion of osteoporotic post-menopausal women at increased risk for upper GI adverse events associated with bisphosphonate therapy. 9:367-370. 2000